245 related items for PubMed ID: 10414395
1. Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone.
Malo JL, Cartier A, Ghezzo H, Mark S, Brown J, Laviolette M, Boulet LP.
Eur Respir J; 1999 May; 13(5):993-8. PubMed ID: 10414395
[Abstract] [Full Text] [Related]
2. Improved safety with equivalent asthma control in adults with chronic severe asthma on high-dose fluticasone propionate.
Berend N, Kellett B, Kent N, Sly PD, Collaborative Study Group of the Australian Lung Foundation.
Respirology; 2001 Sep; 6(3):237-46. PubMed ID: 11555383
[Abstract] [Full Text] [Related]
3. Adrenal function as assessed by low-dose adrenocorticotropin hormone test before and after switching from inhaled beclomethasone dipropionate to inhaled fluticasone propionate.
Niitsuma T, Okita M, Sakurai K, Morita S, Tsuyuguchi M, Matsumura Y, Hayashi T, Koshishi T, Oka K, Homma M.
J Asthma; 2003 Sep; 40(5):515-22. PubMed ID: 14529101
[Abstract] [Full Text] [Related]
4. Fluticasone propionate 750 micrograms/day versus beclomethasone dipropionate 1500 micrograms/day: comparison of efficacy and adrenal function in paediatric asthma.
Fitzgerald D, Van Asperen P, Mellis C, Honner M, Smith L, Ambler G.
Thorax; 1998 Aug; 53(8):656-61. PubMed ID: 9828851
[Abstract] [Full Text] [Related]
5. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
6. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
7. Short-Term Growth During Treatment with Inhaled Fluticasone Propionate/Formoterol, Fluticasone and Beclomethasone Treatment.
Wolthers OD, Moore A, Mersmann S, Dissanayake S.
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):373-380. PubMed ID: 28510491
[Abstract] [Full Text] [Related]
8. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.
Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, van Herwaarden CL.
Am J Respir Crit Care Med; 1996 Mar; 153(3):924-30. PubMed ID: 8630574
[Abstract] [Full Text] [Related]
9. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A, Hall I, Spelman R.
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[Abstract] [Full Text] [Related]
10. Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children.
Adams N, Lasserson TJ, Cates CJ, Jones PW.
Cochrane Database Syst Rev; 2007 Oct 17; 2007(4):CD002310. PubMed ID: 17943772
[Abstract] [Full Text] [Related]
11. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun 17; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
12. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC, Hallett C, Harris TA.
Respir Med; 1998 Jan 17; 92(1):95-104. PubMed ID: 9519232
[Abstract] [Full Text] [Related]
13. Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.
Lorentzen KA, Van Helmond JL, Bauer K, Langaker KE, Bonifazi F, Harris TA.
Respir Med; 1996 Nov 17; 90(10):609-17. PubMed ID: 8959118
[Abstract] [Full Text] [Related]
14. A randomized, double-blind study comparing the effects of beclomethasone and fluticasone on bone density over two years.
Egan JJ, Maden C, Kalra S, Adams JE, Eastell R, Woodcock AA.
Eur Respir J; 1999 Jun 17; 13(6):1267-75. PubMed ID: 10445600
[Abstract] [Full Text] [Related]
15. Systemic effects of inhaled corticosteroids on growth and bone turnover in childhood asthma: a comparison of fluticasone with beclomethasone.
Rao R, Gregson RK, Jones AC, Miles EA, Campbell MJ, Warner JO.
Eur Respir J; 1999 Jan 17; 13(1):87-94. PubMed ID: 10836329
[Abstract] [Full Text] [Related]
16. [Inhaled corticosteroids: first-line therapy in asthma].
Hajiro T, Ishihara K.
Nihon Rinsho; 2001 Oct 17; 59(10):1967-72. PubMed ID: 11676140
[Abstract] [Full Text] [Related]
17. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis.
Lipworth BJ.
Arch Intern Med; 1999 May 10; 159(9):941-55. PubMed ID: 10326936
[Abstract] [Full Text] [Related]
18. Significant variability in response to inhaled corticosteroids for persistent asthma.
Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, Craig TJ, Dolovich M, Drazen JM, Fagan JK, Fahy JV, Fish JE, Ford JG, Israel E, Kiley J, Kraft M, Lazarus SC, Lemanske RF, Mauger E, Peters SP, Sorkness CA, Asthma Clinical Research Network of the National Heart Lung, and Blood Institute.
J Allergy Clin Immunol; 2002 Mar 10; 109(3):410-8. PubMed ID: 11897984
[Abstract] [Full Text] [Related]
19. [Effect of fluticasone propionate at half dose of beclomethasone dipropionate divided twice daily and once daily in asthmatics inhaling beclomethasone dipropionate 800 micrograms daily or more].
Hasegawa T, Tomii K, Kikumoto N, Sakamoto H, Maekawa T, Katayama S, Kamei T, Sakamoto Y, Fujii H, Ishihara K.
Arerugi; 2001 Apr 10; 50(4):379-84. PubMed ID: 11398334
[Abstract] [Full Text] [Related]
20. High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society.
Boe J, Bakke P, Rødølen T, Skovlund E, Gulsvik A.
Eur Respir J; 1994 Dec 10; 7(12):2179-84. PubMed ID: 7713201
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
